A Study to Evaluate the Performance and Safety of Artelac® Complete MDO® Versus VISMED® MULTI Eye Drops in the Management of Moderate to Severe Dry Eye Disease

NCT07593885 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

160

Enrollment

INDUSTRY

Sponsor class

Conditions

Dry Eye

Interventions

DRUG: Artelac® Complete MDO® Eye Drops
DRUG: VISMED® MULTI Eye Drops

Sponsor

Dr. Gerhard Mann chem.-pharm. Fabrik GmbH